Author:
Hasinoff Brian B.,Kuschak Theodore I.,Yalowich Jack C.,Creighton Andrew M.
Subject
Pharmacology,Biochemistry
Reference38 articles.
1. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives;Tanabe;Cancer Res,1991
2. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: Mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors;Ishida;Cancer Res,1991
3. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro;Ishimi;Mol Cell Biol,1992
4. Phase II study: Treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine);Ohno;J Natl Cancer Inst,1992
5. Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16);Sehested;Biochem Pharmacol,1993
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献